Inhibition of TNF-αReverses the Pathological Resorption Pit Profile of Osteoclasts from Patients with Acute Charcot Osteoarthropathy

Inflammatory and bone turnover markers in a cross-sectional and prospective study of acute Charcot osteoarthropathy

(2014) N. L. Petrova et al.   DIABETIC MEDICINE

Steering the osteoclast through the demineralization–collagenolysis balance

(2013) Kent Søe et al.   BONE

Novel Use of a Dektak 150 Surface Profiler Unmasks Differences in Resorption Pit Profiles Between Control and Charcot Patient Osteoclasts

(2013) Nina L. Petrova et al.   CALCIFIED TISSUE INTERNATIONAL

Inflammatory bone loss: pathogenesis and therapeutic intervention

(2012) Kurt Redlich et al.   NATURE REVIEWS DRUG DISCOVERY

The Charcot Foot in Diabetes

(2011) L. C. Rogers et al.   DIABETES CARE

Osteoclast Activity and Subtypes as a Function of Physiology and Pathology—Implications for Future Treatments of Osteoporosis

(2011) K. Henriksen et al.   ENDOCRINE REVIEWS

Mortality Associated With Acute Charcot Foot and Neuropathic Foot Ulceration

(2010) J. van Baal et al.   DIABETES CARE

Proinflammatory Modulation of the Surface and Cytokine Phenotype of Monocytes in Patients With Acute Charcot Foot

(2009) L. Uccioli et al.   DIABETES CARE

Mortality Risk of Charcot Arthropathy Compared With That of Diabetic Foot Ulcer and Diabetes Alone

(2009) M.-W. Sohn et al.   DIABETES CARE

Charcot neuro-osteoarthropathy—current standards

(2008) N. L. Petrova et al.   DIABETES-METABOLISM RESEARCH AND REVIEWS

Increased osteoclastic activity in acute Charcot’s osteoarthopathy: the role of receptor activator of nuclear factor-kappaB ligand

(2008) G. Mabilleau et al.   DIABETOLOGIA